Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Treatment of Erectile Dysfunction (ED) in Patients Treated for Prostate Cancer Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified medical advice, calls or professional assistance using a genuine dr.. We aren't physicians. Always confer with your dr. on Treatment of Erectile Dysfunction (ED) in Patients Treated for Prostate Cancer conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Treatment of Erectile Dysfunction (ED) in Patients Treated for Prostate Cancer Clinical research trials and Treatment of Erectile Dysfunction (ED) in Patients Treated for Prostate Cancer medical trials happen in hundreds of localities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new does drugs. The intent of the studies / undertakings is to answer particular human health questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to find cures for all kinds of circumstances, like Treatment of Erectile Dysfunction (ED) in Patients Treated for Prostate Cancer. Treatment of Erectile Dysfunction (ED) in Patients Treated for Prostate Cancer Clinical Trials and other clinical trials permit volunteers to acquire healthcare treatment options before they are available to the general public. Some times the subjects acquire professional assistance for free, and sometimes they are paid for their time. Sometimes there is a cost for a Treatment of Erectile Dysfunction (ED) in Patients Treated for Prostate Cancer clinical trial. Participants frequently obtain the most expert healthcare available for their Treatment of Erectile Dysfunction (ED) in Patients Treated for Prostate Cancer condition. Dangers are a reality, nevertheless, and can include more or frequent doctor calls, health risks (potentially life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.

Home > "T" Clinical Trials Conditions > Treatment of Erectile Dysfunction (ED) in Patients Treated for Prostate Cancer

Treatment of Erectile Dysfunction (ED) in Patients Treated for Prostate Cancer



Treatment of Erectile Dysfunction (ED) in Patients Treated for Prostate Cancer

For Condition: Prostate Cancer
Status: Recruiting
Sponsor(s): National Institute of Nursing Research (NINR) ,
Synopsis: The purpose of this study is to see if there is a significant difference in erectile function between men treated with sildenafil (FDA approved drug for treatment of erectile dysfunction) versus placebo after radiation therapy (RT) plus neoadjuvant total androgen suppression (TAS) for prostate cancer and to determine if there is a significant difference in overall sexual function and satisfaction between men treated with sildenafil versus placebo.
Details: This is a Phase III study. The study targets men with stage II and III prostate cancer recruited from the Radiation Therapy Oncology Group clinical trial (RTOG 99-10) treated with either 8 or 28 weeks of neoadjuvant TAS and RT with concurrent (8 week duration) TAS.
Eligibility:
Study Type:
  Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Crossover Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 25 Years/65 Years
Genders: Male
Protocol Entry Criteria: - Men with prostate cancer in stages II-III.
Total Enrollment: 332

Location and Contact Information:

American College of Radiology *Recruiting*
Philadelphia,  Pennsylvania,  19107
United States
Recruiting Deborah  Bruner 215-728-2967


Additional Information:
Study ID Numbers:
  1-R01-NR007971-01; 
Study Start Date: September 2001
Record last reviewed: January 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00075127

Other Prostate Cancer Studies:
1. Treatment with Zometa in patients with breast cancer, multiple myeloma, and prostate cancer with cancer related bone lesions

2. Phase I Study of Weekly Intravenous PS-341 Plus Mitoxantrone

3. Perifosine to Treat Prostate Cancer

4. Lycopene In Preventing of Prostate Cancer

5. Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer

Related Studies:

Other Prostate Cancer Clinical Trials
Other Pennsylvania Clinical Trials
Other Philadelphia Clinical Trials

Treatment of Erectile Dysfunction (ED) in Patients Treated for Prostate Cancer

Modify your Search

  Other Prostate Cancer Clinical Trials
  Other Pennsylvania Clinical Trials
  Other Philadelphia Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103